Quincy Bioscience Recognizes the Vital Role of Pharmacists During American Pharmacists Month

Madison, WI (PressExposure) October 23, 2013 -- Quincy Bioscience, creators of Prevagen best-selling memory supplement, recognizes the important role of pharmacists this October for American Pharmacists Month. Quincy Bioscience gives thanks to pharmacists for being a significant component in contributing to the overall health of Americans across the nation.

Pharmacists not only dispense medicine, but also offer valuable advice regarding over-the-counter medicine and dietary supplements in providing for the health of Americans consumers. By educating patients and managing health records each day, pharmacists have become trusted and dependable individuals to patients and a high quality resource for health information.

Recent studies show that Americans take vitamins and supplements more now than ever before, with over half of the adult population being supplement users. Dietary supplements contain essential nutrients and are primarily consumed to improve overall health.

Prevagen is a unique supplement clinically shown to improve memory, focus and concentration. In 2012, Prevagen became the nation's leading brain health supplement in chain drug stores across the country, and continues to remain on top. Prevagen is available in over 20,000 pharmacies nationwide including Walgreens, CVS and Rite Aid.

Quincy Bioscience understands that the leading fear in aging is memory loss. Prevagen was developed to reduce mild memory loss issues associated with aging and to alleviate the concerns of those with a loved one who endures age-related memory loss. Learn more information about Prevagen at http://www.prevagen.com.

Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support good health in aging. The company's products focus on supporting memory and cognitive health. Quincy Bioscience is set apart by its cutting-edge applications of the protein apoaequorin, which is breaking new ground in the area of brain health.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Press Release Submitted On: October 23, 2013 at 11:40 am
This article has been viewed 29206 time(s).